These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6210519)

  • 1. New drug evaluations: moxalactam (Moxam, Eli Lilly).
    Polk RE
    Drug Intell Clin Pharm; 1982 Feb; 16(2):104-12. PubMed ID: 6210519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.
    Fitzpatrick BJ; Standiford HC
    Pharmacotherapy; 1982; 2(4):197-212. PubMed ID: 6221237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
    Goto S
    Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.
    Snepar R; Poporad G; Romano J; Levison ME
    Antimicrob Agents Chemother; 1981 Nov; 20(5):642-7. PubMed ID: 6459763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM; Kaplan SL; Mason EO; Denson S; Pickering LK
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxalactam disodium (Moxam).
    Med Lett Drugs Ther; 1982 Feb; 24(602):13-4. PubMed ID: 6460163
    [No Abstract]   [Full Text] [Related]  

  • 8. Moxalactam in serious infections: clinical, bacteriologic, and pharmacokinetic studies.
    Giamarellou H; Tsagarakis J; Daikos GK
    Rev Infect Dis; 1982; 4 Suppl():S629-38. PubMed ID: 6218576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
    Salzer W; Pegram PS; McCall CE
    Antimicrob Agents Chemother; 1983 Apr; 23(4):565-70. PubMed ID: 6222696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
    Schaad UB; McCracken GH; Threlkeld N; Thomas ML
    J Pediatr; 1981 Jan; 98(1):129-36. PubMed ID: 6450277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxalactam in pediatrics.
    Barson WJ; Nahata MC
    Drug Intell Clin Pharm; 1982 Feb; 16(2):113-4. PubMed ID: 6210520
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
    Digranes A; Benonisen E; Dibb WL; Ostervold B
    Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections.
    Rambo WM; Del Bene VE; Burkey LG; Collins CD; Richmond DK
    Rev Infect Dis; 1982; 4 Suppl():S683-7. PubMed ID: 6218583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of lower respiratory tract infections with moxalactam.
    Lentino JR; Rytel MW; Moore E
    Antimicrob Agents Chemother; 1981 May; 19(5):801-6. PubMed ID: 6457557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.
    Schaad UB; McCracken GH; Loock CA; Thomas ML
    Antimicrob Agents Chemother; 1980 Mar; 17(3):406-11. PubMed ID: 6448576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.
    Preheim LC; Penn RG; Sanders CC; Goering RV; Giger DK
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1037-41. PubMed ID: 6218778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on 6059-S in children (author's transl)].
    Yanagisawa K; Ide K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1981 May; 34(5):757-63. PubMed ID: 6457174
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis.
    Bartlett JG; Joiner KA; Dezfulian M; Marien GJ
    Rev Infect Dis; 1982; 4 Suppl():S664-9. PubMed ID: 6218580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of moxalactam.
    Reed MD; Bertino JS; Aronoff SC; Speck WT; Blumer JL
    Clin Pharm; 1982; 1(2):124-34. PubMed ID: 6224626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.